Nanoparticle Probes for SARS-CoV-2 Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current genetic tests for SARS-CoV-2, particularly PCR-based methods, are limited by their need for specialized laboratories, expensive equipment, and trained personnel, and lack scalability, making them unsuitable for rapid and widespread detection.
Innovation Solution
A nanoparticle-based detection platform utilizing oligonucleotide probe-functionalized nanoparticles that agglomerate in the presence of target nucleic acid sequences, causing a visible color change, which can be detected without complex instruments, allowing for rapid and efficient detection of SARS-CoV-2 RNA in a simple tube setup.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If PCR-based genetic tests are used for SARS-CoV-2 detection, then measurement precision is improved, but device complexity and ease of operation worsen due to requiring specialized laboratories, expensive equipment, and trained personnel
Solution Approach 1:
The patent replaces complex mechanical/electronic PCR equipment with a chemical-based colorimetric detection system using nanoparticles. The detection mechanism shifts from requiring sophisticated thermal cyclers and fluorescence detectors to using simple color changes visible to the naked eye or detectable with basic spectrophotometers, thereby reducing device complexity while maintaining detection capability
Solution Approach 2:
The patent employs disposable nanoparticle probes that can be prepared and used without expensive, reusable equipment. The detection reagents are designed as single-use components that eliminate the need for costly, maintainable instruments, making the system accessible in resource-limited settings
2Measurement precision
If PCR-based genetic tests are used for SARS-CoV-2 detection, then measurement precision is improved, but productivity worsens due to limited scalability and long turn-around time
Solution Approach 1:
The patent segments the detection process into simple, parallelizable steps that can be performed independently in multiple locations simultaneously. Each nanoparticle probe targets specific viral sequences independently, allowing high-throughput screening without requiring centralized laboratory processing, thereby improving productivity and scalability
Solution Approach 2:
The nanoparticle probes are pre-functionalized with oligonucleotide sequences that specifically bind to SARS-CoV-2 genetic material. This preliminary preparation eliminates the need for complex real-time processing during testing, allowing rapid detection and increasing the number of tests that can be performed per unit time
3Ease of operation
If antigenic tests are used for SARS-CoV-2 detection, then ease of operation is improved, but measurement precision worsens due to cross-reactivity with other related proteins
Solution Approach 1:
The patent substitutes protein-based antigen detection with nucleic acid-based detection using nanoparticle probes. Since nucleic acid sequences are more specific than protein structures, this substitution maintains the simplicity of the assay while dramatically improving measurement precision and reducing cross-reactivity with related viruses
4Measurement precision
If antibody tests are used for SARS-CoV-2 detection, then measurement precision is improved compared to antigen tests, but productivity worsens due to delayed detection until 10-14 days after infection
Solution Approach 1:
The nanoparticle probes are designed to detect viral genetic material that is present from the moment of infection, rather than waiting for the immune system to produce antibodies. This preliminary detection capability allows identification of infected individuals immediately, eliminating the 10-14 day delay inherent in antibody tests while maintaining high specificity
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method provides a sensitive and specific means to detect SARS-CoV-2 RNA, offering improved scalability and accessibility, enabling rapid detection by the naked eye within minutes to hours, even in non-specialized settings, with enhanced sensitivity and specificity compared to existing methods.
Implementation Method 1
utilizing oligonucleotide probe-functionalized nanoparticles that agglomerate in the presence of target nucleic acid sequences
Implementation Method 2
nanoparticles that agglomerate in the presence of target nucleic acid sequences, causing a visible color change
Implementation Method 3
causing a visible color change, which can be detected without complex instruments
Data Source
AI summary
The invention provides a method for detecting the presence of a target nucleic acid analyte, for example a pathogen or virus nucleic acid, in a sample using oligonucleotide probe-functionalised nanoparticles, where hybridisation of at least three different oligonucleotide probes to at least three different target sequences in the target analyte causes agglomeration of the nanoparticles and a visible colour change. The invention also provides a population of such oligonucleotide probe-functionalised nanoparticles and a related kit for detection of a target nucleic acid analyte.